Enhancing Telemedicine for T2D

Running, not enrolling · Not applicable

Conditions studied: Type 2 Diabetes

In brief

The goal of this pilot clinical trial is to assess feasibility of an intervention to deliver comprehensive, high-quality diabetes care through telemedicine among adults with type 2 diabetes who use insulin and have multiple chronic health conditions. The main question it aims to answer is: Is an enhanced telemedicine intervention for type 2 diabetes compared to usual telemedicine care feasible? Researchers will compare the enhanced telemedicine intervention to usual telemedicine care to see if there are differences in patient satisfaction or preliminary clinical outcomes. Participants will complete 2-3 telemedicine diabetes care visits over approximately 6 months, as well as complete survey measures with each diabetes care visit. Patients in the intervention group will also receive additional support, including pre-visit preparation phone calls, diabetes self-management education and support aligned with their visits, and post-visit follow-up calls.

Key facts

Study ID

NCT06740435

Run by

University of Pittsburgh

People needed

50

Starts

2025-02-03

Expected to finish

2026-12-01

Last updated by the study team

2026-06-05

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• adults 18 years or older
• Diagnosis of type 2 diabetes based on abbreviated ICD-10 code E11.X in medical record or self-report
• HbA1c greater than or equal to 8% based on most recent value at time of recruitment
• Patients must own or have access to a smart phone, tablet, or home computer with data or internet connection that allows access to video-based visits
• Patient must use insulin
• Patients must have >2 comorbid chronic health conditions
• Be able to provide informed consent
• Reside in Pennsylvania

You may not qualify if…

• Age over 80 based on date of birth in electronic medical record
• Visit with an endocrinologist in the prior 1 years
• Dementia, ESRD, malignancy based on abbreviated ICD-10 codes below in medical record or self-report of associated condition
• Dementia: A81.0x, F01.5x, F02.8x, F03.9x, F10.27, F10.97, F13.27, F13.97, F18.97, F19.17, F19.27, F19.97, G30.x, G31.0x, G31.1, G31.83, G31.85
• Malignancy, except non-melanoma skin cancer: C00.x-C14.x, C15.x-C26.x, C3x.xx, C40.xx-C41.x, C43.x, C4A.xx, C45.x-C49.xx, C50.xxx, C51.x-C58, C60.x-C63.x, C64.x- C68.x, C69.xx-C72.x, C73-C76.x, C7A.xx, C80.xx-C96.x (except C90.x1, C91.x1, C92.x1, C93.x1, C94.x1, C95.x1)
• ESRD N18.6
• Type 1, gestational, or other diabetes based on abbreviated ICD-10 codes below in medical record or self-report of associated condition
• Type 1 diabetes: E10.X
• Gestational diabetes: O24.X, E08.X
• Other diabetes: E09.X, E13.2
• Pregnant or planning to become pregnant in next 6 months
• Currently enrolled in another diabetes management intervention study

Where it is running

• University of Pittsburgh — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.